← Back
$ALDX All transactions

Aldeyra Therapeutics, Inc.

A

$ Value

$0

Shares

632,318

Price

$0

Filed

Mar 31

Insider

Name

Brady Todd C

Title

President and CEO

CIK

0001579179

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

632,318

Footnotes

The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2026. | The bonus units vest ratably in equal annual installments over a four-year period beginning on March 27, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The Reporting Person will be entitled to receive a cash payment for each vested bonus unit, on the earlier of (i) four (4) years from the date of grant or (ii) a Change of Control of the Issuer (as defined in the grant documents), equal in value to the closing price per share of the Company's common stock on The Nasdaq Capital Market on the payment date.

Filing Info

Accession No.

0001193125-26-134631

Form Type

4

Issuer CIK

0001341235

Brady Todd C's History

Date Ticker Type Value
2026-03-27 ALDX A $0
2026-03-27 ALDX A $0
2025-12-17 EVOK D
2025-12-17 EVOK D
2025-12-17 EVOK D
2025-12-16 EVOK U
2025-05-21 EVOK A $0

Other Insiders at ALDX (90d)

Insider Bought Sold Last
Brady Todd C
President and CEO
2026-03-27